afatinib dimaleate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
GIOTRIF afatinib 50 mg (as dimaleate) film coated tablet blister pack AUST R: 201320Active ingredients:
afatinib dimaleate
Dosage form:
Tablet, film coated
Sponsor:
Boehringer Ingelheim Pty Ltd
Phone:
0288758800
|
Deletion from market:
31 Jan 2025
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative strengths are available.
|